Source link : https://www.newshealth.biz/health-news/study-assuages-thyroid-cancer-fears-with-glp-1-receptor-agonists/
A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class. Compared with DPP-4 inhibitors, patients who were newly prescribed a GLP-1 receptor agonist did not have a significantly higher risk of developing thyroid cancer over […]
Author : News Health
Publish date : 2024-04-10 21:34:27
Copyright for syndicated content belongs to the linked Source.
Categories